Vir Biotechnology Announces Chief Financial Officer Transition
Vir Biotechnology announced that Chief Financial Officer Jason O’Byrne is leaving the company to pursue another opportunity, with his last day scheduled for August 3. Brent Sabatini, Senior Vice President and Chief Accounting Officer, has been appointed Interim Principal Financial Officer effective immediately.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.